JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis

  • 0Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital of Southwest Medical University, Sichuan, China; Academician (Expert) Workstation of Sichuan Province, Metabolic Hepatobiliary and Pancreatic Diseases Key Laboratory of Luzhou City, The Affiliated Hospital of Southwest Medical University, Sichuan, China.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract +

|

April 7, 2024

|

April 7, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

High modified Glasgow prognostic score (mGPS) indicates poorer outcomes for biliary tract cancer (BTC) patients. This finding suggests mGPS could aid in predicting overall survival and disease-free survival in BTC management.

Area Of Science

  • Oncology
  • Clinical Prognostics

Background

  • Biliary tract cancer (BTC) has high recurrence rates, necessitating improved adjuvant therapies.
  • The modified Glasgow prognostic score (mGPS) is a potential prognostic indicator in BTC.
  • Existing research lacks consensus on the prognostic value of mGPS in BTC.

Conclusions

  • High mGPS is linked to worse overall survival in BTC patients.
  • High mGPS is associated with reduced disease-free/recurrence-free survival in BTC.
  • mGPS demonstrates prognostic utility for predicting outcomes in biliary tract cancer.

Keywords: